| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.1M | — | -8.8% |
| Cost of Revenue | $547K | — | +344.7% |
| Gross Profit | $600K | — | -47.1% |
| R&D Expense | $448K | — | -7.4% |
| SG&A Expense | $11.8M | — | +173.6% |
| Operating Income | -$11.8M | — | -203.0% |
| Pre-tax Income | -$8.4M | — | -135.6% |
| Net Income | -$8.4M | +0.0% | -136.8% |
| EPS (Basic) | -$0.04 | +0.0% | +0.0% |
| EPS (Diluted) | -$0.04 | +0.0% | +0.0% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $271.8M | +40.4% | +1270.9% |
| Short-term Investments | $56.7M | -2.8% | +252.8% |
| Accounts Receivable | $1.9M | +6.2% | -10.6% |
| Inventory | $1.9M | +36.1% | +34.5% |
| Current Assets | $332.6M | +30.2% | +742.9% |
| Total Assets | $349.4M |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.6M | — | +55.4% |
| Capital Expenditures | $71K | — | -9.0% |
| Investing Cash Flow | $1.5M | — | +505.3% |
| Financing Cash Flow | $78.2M | — | +746.8% |
| Free Cash Flow | -$1.7M | — | +54.4% |
| +579.4% |
| Current Liabilities | $9.3M | +291.4% | +837.3% |
| Long-term Debt | $112K | -5.1% | — |
| Total Liabilities | $9.7M | +233.2% | +526.7% |
| Stockholders' Equity | $339.7M | +25.9% | +580.9% |